✦ LIBER ✦

T1048 No New Safety Signals Identified in Crohn's Disease Patients Treated with Infliximab in An Interim Review of the ENCORE Registry

✍ Scribed by Colombel, Jean-Frédéric; Prantera, Cosimo; Rutgeerts, Paul J.; Panes, Julian; Fleig, Wolfgang E.; D'Haens, Geert; Bokemeyer, Bernd; Barai, Usha; Wiekowski, Maria

Book ID: 122746339
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 123 KB
Volume: 134
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(08)62209-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P013 NO NEW SAFETY SIGNALS IDENTIFIED IN

P013 NO NEW SAFETY SIGNALS IDENTIFIED IN CROHN'S DISEASE PATIENTS TREATED WITH INFLIXIMAB IN AN INTERIM REVIEW OF THE ENCORE REGISTRY

✍ J.F. Colombel; G. D'Haens; P. Rutgeerts; J. Panes; W.E. Fleig; C. Prantera; B. B 📂 Article 📅 2008 🏛 Oxford University Press ⚖ 118 KB

The TREAT registry data: Long-term safet

The TREAT registry data: Long-term safety of infliximab in patients with Crohn's disease

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 51 KB

DOP099 Five-year safety results from the

DOP099 Five-year safety results from the ENCORE registry: Malignancies in patients with Crohn's disease treated with infliximab, standard therapy, or switched from standard therapy to infliximab

✍ D'Haens, G.; Reinisch, W.; Colombel, J.-F.; Panes, J.; Ghosh, S.; Prantera, C.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 47 KB